Search Results - Mark Maginn

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Evaluation of NTP42, a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial by Helen M. Reid, Mark Maginn, C. Michael Perkins, Eamon P. Mulvaney, Malcolm Boyce, Takahiro Yamamoto, B. Therese Kinsella

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: